GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	27.68B +669.7%
Revenue (ttm)	3.73B +24.7%
Net Income	213.23M +22.6%
EPS	2.55 +22.6%
Shares Out	83.51M
PE Ratio	129.82
Forward PE	n/a
Dividend	1.00 (0.24%)
Ex-Dividend Date	Jan 12, 2026

Volume	449,150
Open	345.25
Previous Close	345.25
Day's Range	280.00 - 414.30
52-Week Range	42.73 - 414.30
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2025, GlaxoSmithKline S.A.E's revenue was 3.73 billion, an increase of 24.73% compared to the previous year's 2.99 billion. Earnings were 213.23 million, an increase of 22.56%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 5, 2026

Data Sources Report a data error